Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-027544
Filing Date
2017-05-15
Accepted
2017-05-15 16:37:38
Documents
65
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v466525_10q.htm 10-Q 554989
2 EXHIBIT 31.1 v466525_ex31-1.htm EX-31.1 8667
3 EXHIBIT 31.2 v466525_ex31-2.htm EX-31.2 9080
4 EXHIBIT 32.1 v466525_ex32-1.htm EX-32.1 4187
5 EXHIBIT 32.2 v466525_ex32-2.htm EX-32.2 3972
  Complete submission text file 0001144204-17-027544.txt   5261871

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ibio-20170331.xml EX-101.INS 1305994
7 XBRL TAXONOMY EXTENSION SCHEMA ibio-20170331.xsd EX-101.SCH 40995
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ibio-20170331_cal.xml EX-101.CAL 35992
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ibio-20170331_def.xml EX-101.DEF 312957
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20170331_lab.xml EX-101.LAB 320956
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20170331_pre.xml EX-101.PRE 346992
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 17844939
SIC: 2834 Pharmaceutical Preparations